ARCHIVES

Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock

This article is from The Cancer Letter archive.

Vol. 39 No. 45 | December 17, 2013

Download PDF Visit The Full Archive

Related Articles

President’s FY 1991 Budget Provides NCI 3.9% Increase, But Grant Budgets To Be Cut 20%

February 2, 1990

Cancer Patient Medical history System Proposed

July 13, 1979

Bahama Government Closes Clinic “Immediately And Permanently” After AIDs Contamination Report

July 26, 1985

NCAB Asks Government To Take Steps Aimed at Reducing Health Hazards From Cigarettes

December 21, 1973

NCI CTEP Approved Trials For the Month of August

August 30, 2013

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013